akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prosztata daganatok, kasztráció-rezisztens - daganatellenes szerek - treatment of adult patients with prostate cancer.
finasterid orion 5 mg filmtabletta
orion corporation - finasteride -
vantas 50 mg implantátum
orion corporation - histrelin -
decapeptyl depot por és oldószer szuszpenziós injekcióhoz
ferring magyarország kft. - triptorelin -
suprefact depot 3 hónap implantátum
sanofi-aventis zrt. - buserelin -
xtandi
astellas pharma europe b.v. - enzalutamide - prosztatikus daganatok - endokrin terápia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
suprefact depot 2 hónap implantátum
sanofi-aventis zrt. - buserelin -
diphereline sr 22,5 mg por és oldószer retard szuszpenziós injekcióhoz
ipsen pharma - triptorelin -
suprefact oldatos injekció
cheplapharm arzneimittel gmbh - buserelin -
suprefact oldatos orrspray
sanofi-aventis zrt. - buserelin -